Sichuan Kelun Pharmaceutical Co.,Ltd.’s Net Profit Rose 96.2% in First Three Quarters of 2022
Listen to the full version

Sichuan Kelun Pharmaceutical Co.,Ltd. (四川科伦药业股份有限公司) (002422.SZ) reported a net profit of 1.5 billion yuan in the first three quarters of 2022, up 96.2% year-on-year.
Meanwhile, the company posted 13.9 billion yuan in revenue, up 9.2% year-on-year.
At the end of the reporting period, it had 33.5 billion yuan in total assets and 18.1 billion yuan in total liabilities, with a liability-to-asset ratio of 54.1%.
Unlock exclusive discounts with a Caixin group subscription — ideal for teams and organizations.
Subscribe to both Caixin Global and The Wall Street Journal — for the price of one.
- PODCAST
- MOST POPULAR